Orphan/rare drug discovery through drug repositioning

Download Type: Adobe PDF

In this article Ramaiah Muthyala discusses new approaches to developing therapeutic options for orphan diseases.

He discusses how new approaches are bringing big pharma resources to solving the problem through drug repositioning of approved drugs. He also discusses how advances are being spurred by public and private partnerships, government incentives and awareness brought by patient support groups.

Share this download

More services